DE602006008349D1 - Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel - Google Patents

Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel

Info

Publication number
DE602006008349D1
DE602006008349D1 DE602006008349T DE602006008349T DE602006008349D1 DE 602006008349 D1 DE602006008349 D1 DE 602006008349D1 DE 602006008349 T DE602006008349 T DE 602006008349T DE 602006008349 T DE602006008349 T DE 602006008349T DE 602006008349 D1 DE602006008349 D1 DE 602006008349D1
Authority
DE
Germany
Prior art keywords
inflammatory
compounds
amido
quaternary
anion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602006008349T
Other languages
English (en)
Inventor
Jacques Gosteli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CERECON AG
Original Assignee
CERECON AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CERECON AG filed Critical CERECON AG
Publication of DE602006008349D1 publication Critical patent/DE602006008349D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DE602006008349T 2005-12-09 2006-11-29 Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel Expired - Fee Related DE602006008349D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH19542005 2005-12-09
PCT/CH2006/000672 WO2007065281A1 (en) 2005-12-09 2006-11-29 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents

Publications (1)

Publication Number Publication Date
DE602006008349D1 true DE602006008349D1 (de) 2009-09-17

Family

ID=37913716

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006008349T Expired - Fee Related DE602006008349D1 (de) 2005-12-09 2006-11-29 Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel

Country Status (7)

Country Link
US (1) US20080249140A1 (de)
EP (1) EP1963270B1 (de)
AT (1) ATE438625T1 (de)
CA (1) CA2629913A1 (de)
DE (1) DE602006008349D1 (de)
MX (1) MX2008007259A (de)
WO (1) WO2007065281A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2702898C2 (ru) * 2014-09-10 2019-10-14 Гск Консьюмер Хелткер С.А. Композиции диклофенака натрия для местного применения
ES2967074T3 (es) * 2016-07-18 2024-04-25 Pharmena S A 1 metilnicotinamida para el tratamiento de una enfermedad cardiovascular
CA3055159A1 (en) 2017-03-07 2018-09-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Topical delivery systems for active compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3340028A1 (de) * 1983-11-03 1985-05-15 Josef Dipl.-Chem. Dr.Rer.Nat. Klosa Neues salicylsaeuresalz
PL190755B1 (pl) * 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
PL364348A1 (en) * 2004-01-12 2005-07-25 PHARMENA Sp.z o.o. Application of quaternary pyridine salts as vessel protection agent

Also Published As

Publication number Publication date
MX2008007259A (es) 2008-09-23
EP1963270B1 (de) 2009-08-05
EP1963270A1 (de) 2008-09-03
US20080249140A1 (en) 2008-10-09
ATE438625T1 (de) 2009-08-15
WO2007065281A1 (en) 2007-06-14
CA2629913A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
CY1120141T1 (el) Παραγωγο βενζαμιδιου ως αναστολεας απακετυλασης ιστονης με ισχυρη διαφοροποιητικη και αντιπολλαπλασιαστικη δραστικοτητα
CY1115058T1 (el) Παραγωγα 1,2,3- τριαζολης για χρηση ως αναστολεις στεατοϋλο-coa δεσατουρασης
BRPI0908353B8 (pt) composto ou um sal farmaceuticamente aceitavel do mesmo e composição farmaceutica
BR112012008317A2 (pt) produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal
UA108363C2 (uk) Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
BRPI0612287A8 (pt) composição para uso farmacêutico no tratamento de doenças através da medicina nuclear e métodos de uso e para modulação de atividade de receptor nuclear
BR112014031730A2 (pt) entidades químicas, composições farmacêuticas, compostos ou sais farmaceuticamente aceitáveis dos mesmos, usos de entidades químicas ou composições e métodos para tratar doenças, distúrbios ou condições médicas mediadas pela atividade enzimática de pde1 e para modular a atividade da enzima pde1
BRPI0408486A (pt) derivados de biciclopirazol ativos como inibidores da cinase, processo para a sua preparação e composições farmacêuticas compreendendo-os
JP2012144490A (ja) 外用組成物
ATE425961T1 (de) Salze substituierter allophansaureester und deren verwendung in arzneimitteln
BRPI0607614A2 (pt) sal de besilato da 7-(2-(4-3-trifluorometil-fenil)-1,2,3,6-tetrahidropirid- 1-il)etil) isoquinoleìna, o respectivo medicamento, composição farmacêutica e uso
BR112014028813A2 (pt) 5-amino[1,4]tiazinas como inibidores bace1
NO20084478L (no) Konjugerte lipidderivater
BRPI0607918A2 (pt) tetraidro-piridoazepin-8-onas e compostos relacionados para o tratemento da esquizofrenia.
ATE438625T1 (de) Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
HRP20060079A2 (en) Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
Li et al. Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1, 12-diaziridinyl-4, 9-diazadodecane
EA201000701A1 (ru) 4-[4-(2-адамантилкарбамоил)-5-трет-бутилпиразол-1-ил]бензойная кислота-465
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
ATE378335T1 (de) Chirale fluorochinolizinon arginine salze
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
Sharma et al. Design of Fmoc-Phenylalanine Nanofibrillar Hydrogel and Mechanistic Studies of Its Antimicrobial Action against Both Gram-Positive and Gram-Negative Bacteria
HRP20050815A2 (en) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
ATE490233T1 (de) Neuartige rar-rezeptoragonisten-liganden und deren verwendung in der humanmedizin und kosmetik

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee